LBX Pharmacy Chain Joint Stock Company

Shanghai Stock Exchange 603883.SS

LBX Pharmacy Chain Joint Stock Company Net Income for the year ending December 31, 2023: USD 130.85 M

LBX Pharmacy Chain Joint Stock Company Net Income is USD 130.85 M for the year ending December 31, 2023, a 15.04% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.

LBX Pharmacy Chain Joint Stock Company Net Income for the year ending December 31, 2022 was USD 113.75 M, a 8.00% change year over year.
LBX Pharmacy Chain Joint Stock Company Net Income for the year ending December 31, 2021 was USD 105.32 M, a 10.69% change year over year.
LBX Pharmacy Chain Joint Stock Company Net Income for the year ending December 31, 2020 was USD 95.15 M, a 30.25% change year over year.
LBX Pharmacy Chain Joint Stock Company Net Income for the year ending December 31, 2019 was USD 73.05 M, a 15.49% change year over year.

Key data

Date	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)	Net Income Margin

Shanghai Stock Exchange: 603883.SS

LBX Pharmacy Chain Joint Stock Company

CEO	Mr. Xin Wan
IPO Date	April 23, 2015
Location	China
Headquarters	No. 1 (Xingsha) Kaiyuanxi Road
Employees	40,881
Sector	Health Care
Industries Drugstores & Retail Pharmacies Pharmaceuticals

Description

LBX Pharmacy Chain Joint Stock Company operates pharmacy store chain in China. The company operates stores in 21 provincial markets, including Hunan, Jiangsu, Gansu, Shaanxi, Guangxi, Anhui, Zhejiang, Inner Mongolia, Hubei, Tianjin, Henan, Shanghai, Shandong, Guangdong, Hebei, Beijing, Jiangxi, Ningxia, Sichuan, Fujian, and Guizhou. The company was formerly known as Laobaixing Pharmacy Chain Joint Stock Company. LBX Pharmacy Chain Joint Stock Company was founded in 2001 and is based in Changsha, China.

Key trends

Past 5 years